Neuroglee Therapeutics

Neuroglee Therapeutics develops and commercializes software as a medical treatment for patients with neurodegenerative diseases. By combining top-tier cognitive rehabilitation strategies with machine learning approaches, Neuroglee Therapeutics' digital treatment and monitoring tools empower patients, families, and clinicians by helping users maintain cognition and independence. The company’s lead product, NG-001, is a prescription software designed for treating MCI and early-stage Alzheimer’s disease.